Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs

J Rheumatol. 2021 Aug;48(8):1343-1344. doi: 10.3899/jrheum.200483. Epub 2020 Apr 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Biological Products* / therapeutic use
  • COVID-19*
  • Child
  • Humans
  • Rheumatic Diseases* / drug therapy
  • SARS-CoV-2

Substances

  • Antirheumatic Agents
  • Biological Products